MedTrace Logo

Study to Assess if Internet-Based Tailored Advice Could Modify Behaviour to Improve Health

NCT00220974 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3708

Last updated 2009-02-13

No results posted yet for this study

Summary

The purpose of this trial is to find out if a special website might help people discover if they have high cholesterol and then enable them to manage their cholesterol more appropriately. The primary aim of this trial is to determine the effects on consumers' use of cholesterol lowering therapy of an online service that provides automated, individually tailored, advice about eligibility for cholesterol lowering treatment. The primary null hypothesis being tested is that the service will result in no change in the use of cholesterol lowering treatments by consumers that use the service.

The secondary aim of the trial is to see if it is possible to improve the cholesterol management of the friends or relatives of consumers that use the I-CAT service. The corresponding secondary null hypothesis being tested is that the I-CAT service will result in no change in the use of cholesterol lowering treatments by the friends or relatives of the consumers that use the service.

Conditions

Interventions

BEHAVIORAL

Internet-based tailored advice on cardiovascular risk

Sponsors & Collaborators

  • Lipid and Cardiovascular Risk Assessment Service, ICPMR, Westmead Hospital

    collaborator UNKNOWN

  • Royal Prince Alfred Hospital, Sydney, Australia

    collaborator OTHER

  • Pfizer

    collaborator INDUSTRY

  • Medical benefit Fund (MBF)

    collaborator UNKNOWN

  • The George Institute

    lead OTHER

Principal Investigators

  • Bruce Neal, MB BS PhD · The George Institute

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2006-12-31
Completion
2006-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00220974 on ClinicalTrials.gov